PILOCYTIC ASTROCYTOMA
Clinical trials for PILOCYTIC ASTROCYTOMA explained in plain language.
Never miss a new study
Get alerted when new PILOCYTIC ASTROCYTOMA trials appear
Sign up with your email to follow new studies for PILOCYTIC ASTROCYTOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New proton therapy aims to shield Kids' memories during brain tumor treatment
Disease control Recruiting nowThis study tests a special proton therapy technique that avoids the memory center of the brain (hippocampus) in children with low-grade glioma. The goal is to see if this approach is possible and helps preserve memory and thinking skills. About 74 children will take part, and res…
Matched conditions: PILOCYTIC ASTROCYTOMA
Phase: NA • Sponsor: St. Jude Children's Research Hospital • Aim: Disease control
Last updated May 17, 2026 00:53 UTC
-
New pill takes on brain tumors: first human trial begins
Disease control Recruiting nowThis early-stage trial tests an oral drug called ONC206 in adults with brain tumors that have come back. The main goal is to find the safest dose and understand side effects. About 102 participants will receive the drug weekly or multiple days per week.
Matched conditions: PILOCYTIC ASTROCYTOMA
Phase: PHASE1 • Sponsor: Jazz Pharmaceuticals • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
Kids' brain tumor drug combo gets Long-Term safety check
Disease control Recruiting nowThis study follows children who previously took dabrafenib and/or trametinib for certain brain tumors. It aims to see how safe these drugs are over the long term by tracking side effects and monitoring growth. About 163 children are enrolled, and the study is no longer recruiting…
Matched conditions: PILOCYTIC ASTROCYTOMA
Phase: PHASE4 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated May 15, 2026 11:54 UTC